
11 - 50 employees
5AM was founded in 2002 and pursues investments in advanced life science innovations, and seeks to be diversified across the biopharmaceutical therapeutics, and platform technologies. Within each sector, 5AM invests across multiple therapeutic areas and modalities and evaluates opportunities based on innovative platform technologies, corporate spin-offs and products with shorter development cycles.
🔥 2 hours ago
11 - 50
Director/Senior Director leading operational foundation for clinical development at Renasant Bio. Advancing kidney disease programs in collaboration with various teams and stakeholders.